Varian

What Varian does

Varian, a Siemens Healthineers company headquartered in Palo Alto, California, is a global oncology technology platform serving hospitals, cancer centers, and integrated health systems. Originally founded in 1948 by Grant and Russell Varian, the company has evolved from its origins in klystron tubes into a vertically integrated radiation oncology franchise spanning linear accelerators (TrueBeam, Halcyon, Edge), the Ethos AI-driven adaptive radiotherapy system, brachytherapy afterloaders (BRAVOS, GammaMedplus iX), interventional oncology devices (IntelliBlate, Isolis cryoprobe, Embozene/Oncozene microspheres), and a comprehensive software portfolio anchored by the ARIA CORE oncology management system alongside Eclipse treatment planning, RapidArc Dynamic, RapidPlan, Velocity, and the Noona patient engagement platform.

The company's business model combines high-ticket capital equipment sales with a growing recurring revenue base of software subscriptions, service contracts (e.g., PremierAssurance), professional services through Advanced Oncology Solutions, and consumables. Distribution is executed through a direct enterprise field sales motion targeting cancer centers and integrated delivery networks globally, augmented by Siemens Healthineers' installed base of 600,000+ imaging systems worldwide and supported by clinical education, medical affairs, and conference-driven marketing. Varian operates as a wholly-owned subsidiary of Siemens Healthineers following a ~$16.4 billion acquisition in 2021; the NYSE:VAR ticker has been discontinued, and Varian's financial performance is now reported within Siemens Healthineers segment disclosures rather than as a standalone public entity.

The technology stack is platform-based, with ARIA CORE serving as the integrating layer across radiation oncology, systemic therapy, and theranostics workflows. AI capability is embedded at multiple layers, including Ethos adaptive therapy, AI-based contouring on HyperSight CBCT imaging (with reported contouring time reductions of up to ~90%), knowledge-based planning via RapidPlan, and AI-Rad Companion Organs RT for radiosurgery. Recent strategic moves include FDA 510(k) clearance expanding TrueBeam into osteoarthritis, an ARPA-H award (with Siemens cost share) of up to $83M for photon Flash radiotherapy, a 10-year $260M collaboration with Ballad Health described as one of Varian's largest deals, a theranostics partnership with Telix Pharmaceuticals, and Siemens' $150M U.S. manufacturing investment including relocation of Varian operations to Palo Alto.

Name

Varian

Legal name

Varian Medical Systems, Inc. - A Siemens Healthineers Company

Website

https://varian.com

Company type

Private

Founded year

1948

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Varian, a Siemens Healthineers subsidiary, provides a vertically integrated radiation oncology platform, including linear accelerators (TrueBeam, Halcyon, Edge), Ethos adaptive radiotherapy, brachytherapy systems, interventional oncology devices, and ARIA CORE software, serving hospitals, cancer centers, and integrated health systems globally.

Ownership category

akta.pro rank

Product category

Radiation Oncology Equipment

NAICS

Irradiation Apparatus Manufacturing (334517), Surgical and Medical Instrument Manufacturing (339112), Software Publishers (5132)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Radiation Oncology (HLAKAFAC)

akta.pro secondary industries

Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim) (HLAHABAH), Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG)

Keywords

• Radiation oncology equipment
• Treatment planning software
• Medical linear accelerators
• Adaptive radiotherapy systems
• Oncology management software

Headquarters

HQ city

Palo Alto

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Capital Equipment Sales: Sale of radiotherapy systems including TrueBeam, Halcyon, Edge, and Ethos linear accelerators. High-ticket capital equipment sales to hospitals and cancer centers with long sales cycles.
2. Software Subscriptions and Licenses: Oncology management software including ARIA CORE, Eclipse treatment planning, RapidPlan knowledge-based planning, and Velocity analytics software sold through perpetual licenses and subscriptions.
3. Service Contracts and Support: PremierAssurance and other service contracts providing ongoing support, maintenance, and software updates for installed systems.
4. Professional Services: Advanced Oncology Solutions including clinical services, professional services, and consulting to help cancer centers optimize and standardize operations.
5. Consumables and Accessories: Treatment delivery consumables and accessories for radiotherapy procedures.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Varian, a Siemens Healthineers company, manufactures and sells radiation oncology medical devices and software for cancer treatment. Its core offering includes linear accelerators (TrueBeam, Halcyon, Edge), the Ethos adaptive radiotherapy system with AI, the ARIA CORE oncology management software platform, and Eclipse treatment planning software. The portfolio also spans brachytherapy afterloaders, interventional oncology ablation and embolization systems, imaging solutions for radiotherapy, and managed/clinical services for oncology operations.

Product overview

Varian, a Siemens Healthineers company, offers a comprehensive, platform-based oncology portfolio spanning radiation therapy, brachytherapy, interventional oncology, adaptive therapy, and software solutions. The core offering includes TrueBeam and Halcyon linear accelerators for external beam radiation therapy, Edge radiosurgery platform, and Ethos adaptive radiotherapy system. Treatment planning is supported through Eclipse (including proton therapy module), RapidArc Dynamic, and RapidPlan knowledge-based planning. Software solutions center on ARIA CORE oncology management system (including modules for theranostics and systemic therapy), Velocity treatment planning integration, and Noona patient engagement. Interventional oncology offerings include IntelliBlate microwave ablation, CryoCare Touch/Isolis cryoablation, and Embozene/Oncozene embolization microspheres. The portfolio is unified through AI-powered capabilities (Ethos adaptive therapy, RapidPlan optimization, AI-based contouring) and supported by comprehensive services (Advanced Oncology Solutions) enabling a connected cancer care approach from screening through survivorship.

Differentiator

Problem solved

Functional benefit

Products and services

• TrueBeam Advanced linear accelerator (LINAC) for image-guided radiation therapy enabling precise treatment delivery for complex cancer cases with reduced treatment time and side effects.
• Halcyon Streamlined radiotherapy system designed for efficiency with automated workflows, offering image-guided volumetric modulated arc therapy for cancer treatment.
• Edge Radiosurgery platform for precise, non-invasive treatment of tumors and lesions throughout the body, featuring advanced motion management.
• Ethos Adaptive Radiotherapy System AI-powered adaptive radiotherapy system that continuously adapts treatment based on daily anatomical changes, delivering personalized and precise radiation therapy.
• ARIA CORE Comprehensive oncology management system providing seamless flow of patient data across radiation oncology, systemic therapy, and theranostics workflows.
• Eclipse Treatment Planning Treatment planning system for external beam radiation therapy providing automated planning tools, dose calculation, and plan optimization.
• RapidArc Dynamic Volumetric modulated arc therapy (VMAT) treatment planning and delivery system enabling faster, more precise radiation treatments.
• RapidPlan Knowledge-Based Planning Knowledge-based planning module that uses statistical models derived from historical treatment plans to generate optimized treatment plans.
• HyperArc Radiosurgery Planning Radiosurgery treatment planning module enabling automated, high-quality treatment plans for multiple brain metastases in a single session.
• HyperSight Cone-Beam CT Imaging Cone-beam CT imaging system providing enhanced image quality for adaptive treatment planning and tumor targeting.
• BRAVOS Brachytherapy Afterloader Multichannel afterloader system for high-dose-rate brachytherapy providing precise, automated radiation treatment delivery.
• IntelliBlate Microwave Ablation Microwave ablation system for interventional oncology providing minimally invasive treatment options for tumor ablation.
• Isolis Cryoprobe Cryoprobe system for cryoablation procedures enabling precise tissue ablation through controlled freezing.
• Advanced Oncology Solutions Comprehensive suite of clinical, professional, and consulting services including clinical services, professional services, and the Therapeutic Medical Physics Residency Program to optimize and standardize oncology operations.
• Next-Generation Proton Therapy Platform Next-generation proton therapy platform with enhanced imaging integration capabilities.
• TrueBeam Low-Dose Radiotherapy for Osteoarthritis FDA 510(k)-cleared application of TrueBeam radiotherapy systems for low-dose radiation therapy in adults with medically refractory osteoarthritis, expanding the platform beyond cancer care into chronic musculoskeletal conditions.

Quantifiable outcome

• Treatment sessions reduced from approximately 20 minutes to under 10 minutes using TrueBeam with volumetric modulated arc therapy
• +2 more outcomes

Named customers4 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature10 records

Partnerships

Five partnerships are on record, tiered flagship and core.

• Ballad HealthflagshipStrategic or Co-development Partner · 18 May 202610-year $260 million transformational oncology collaboration deploying 8 TrueBeam linear accelerators, 1 Ethos system with AI capabilities, and ARIA CORE/Eclipse software across 6 cancer centers in Tennessee and Virginia. Described as one of the largest partnerships in Varian's history.
• ARPA-H (Advanced Research Projects Agency for Health)coreStrategic or Co-development Partner · 30 April 2026ARPA-H awarded Varian up to $60 million over five years to accelerate photon Flash radiotherapy development, with Siemens Healthineers contributing $23 million cost share, totaling up to $83 million commitment to advance ultra-high dose rate cancer treatment.
• Telix PharmaceuticalscoreStrategic or Co-development Partner · 11 December 2025Partnership to advance oncologic therapies by combining Telix's radiopharmaceuticals with Varian's external beam radiation therapy capabilities to personalize prostate cancer patient treatment and monitor efficacy.
• Telix PharmaceuticalscoreStrategic or Co-development Partner · 10 December 2025Strategic clinical collaboration to integrate Telix's PSMA-PET imaging agents (Illuccix and Gozellix) with Varian's external beam radiation therapy for prostate cancer treatment and research, including patient selection and treatment monitoring.
• Aspekt SolutionscoreStrategic or Co-development Partner · 26 September 2023Acquisition of Aspekt Solutions to expand advanced oncology solutions offerings, enhancing Varian's ability to support cancer centers with tailored, standardized care and advanced technology.

Scale indicators3 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• RaySearch Laboratories: RaySearch develops treatment planning software (RayStation) and oncology information systems (RayCare), competing with Varian's Eclipse and ARIA CORE in radiation oncology software.
• Elekta: Elekta is Varian's most direct global competitor in linear accelerators (Versa HD, Elekta Unity MR-LINAC), brachytherapy (Flexitron), and treatment planning software (Monaco). It is the closest 1:1 comparable in radiation oncology hardware and software.
• Accuray: Accuray manufactures CyberKnife and TomoTherapy radiation therapy systems, competing head-to-head with Varian's Edge radiosurgery and TrueBeam platforms, especially in stereotactic and image-guided radiotherapy.
• Brainlab: Brainlab offers ExacTrac patient positioning, Elements treatment planning software, and Novalis radiosurgery, overlapping with Varian's IDENTIFY, Eclipse, and HyperArc products.

Emerging players

• RefleXion Medical: RefleXion develops biology-guided radiotherapy (BgRT) using PET signals for tumor targeting, an emerging modality that competes with Varian's TrueBeam and Ethos in oligometastatic and lung cancer indications.
• ViewRay: ViewRay pioneered MR-guided radiation therapy with the MRIdian system, directly competing with Varian's Ethos adaptive platform by offering real-time MRI-based soft-tissue visualization during treatment.
• Mevion Medical Systems: Mevion focuses on compact proton therapy systems (MEVION S250i with HYPERSCAN pencil-beam scanning), competing with Varian's ProBeam proton therapy in the compact proton segment.

Others

• Siemens Healthineers: Siemens Healthineers is Varian's parent company and supplies imaging systems (CT, MRI, PET) used alongside Varian's radiotherapy solutions, including integrated offerings such as NAEOTOM Alpha.Prime RT Pro Edition.

Broad incumbents

• GE HealthCare: GE HealthCare offers CT, MRI, and PET/CT imaging widely used in radiotherapy simulation and planning, overlapping with Varian's imaging-for-radiotherapy portfolio and competing in the broader oncology care continuum.
• Philips: Philips is a broad incumbent in oncology imaging, treatment planning (Pinnacle), and patient monitoring, with overlapping radiotherapy imaging and informatics offerings used alongside Varian's products.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/VarianMedicalSystems
• LinkedInlinkedin.com/company/varian-medical-systems
• Xx.com/VarianMedSys

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A34 records

Investments13 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Varian